All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @extraleonardo on TikTok · 55s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @extraleonardo's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Here's how to dose your first test only cycle without turning yourself into a hormonal disaster.
  2. 0:05For most beginners, you want to be running between 3 to 5 milligrams of test a per kilo
  3. 0:10of body weight per week.
  4. 0:11That's usually around 300 to 400 milligrams a week for the average guy.
  5. 0:15If you're 90 kilos, 90 times 4 equals 360 milligrams per week to start.
  6. 0:21Now, if you're responding well and your bloods will clean by week 6 and you want to push it a bit,
  7. 0:26you can bump the dose to 4 to 6 milligrams per kilo.
  8. 0:29And this is still within reason, not a clown cycle.
  9. 0:32The goal here isn't to blast more gear, it's to find your sweet spot.
  10. 0:36How much test can you handle before you need to start managing estrogen?
  11. 0:40If your natural test is sitting at that 900 mark or higher, then you might start close
  12. 0:44up to the 5 to 6 milligram per kilo dose.
  13. 0:47Everyone's different, but chasing numbers instead of bug work is how most of you crash
  14. 0:51your hormones before even growing any muscle.

@extraleonardo's TRT claims need some fact-checking

Leonardo Bacha

TikTok creator

162.9K viewsWatch on TikTok

Quick answer

The video describes supraphysiologic testosterone dosing (300-600mg/week) in a bodybuilding context, which is distinct from medically supervised TRT for hypogonadism (typically 50-200mg/week). At the dose ranges described, exogenous testosterone suppresses endogenous HPG axis function rapidly and elevates testosterone levels well beyond the physiological reference range, increasing risks for polycythemia, dyslipidemia, and cardiovascular remodeling. Bloodwork monitoring at week 6, while advisable, may not capture all emerging adverse changes, particularly early lipid and hematocrit shifts.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @extraleonardo's TRT claims need some fact-checking, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@extraleonardo's TRT claims need some fact-checking should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@extraleonardo's TRT claims need some fact-checking" from Leonardo Bacha. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video describes supraphysiologic testosterone dosing (300-600mg/week) in a bodybuilding context, which is distinct from medically supervised TRT for hypogonadism (typically 50-200mg/week).

The reason this review is not generic is the source wording and the canonical claim label "trt this is not medical advice but for educational entertainmen." In this clip, the useful excerpt is: "Here's how to dose your first test only cycle without turning yourself into a hormonal disaster." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The doses described in this video are 2-5 times higher than standard therapeutic TRT doses (50-200mg/week) used to treat diagnosed hypogonadism.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video describes supraphysiologic testosterone dosing (300-600mg/week) in a bodybuilding context, which is distinct from medically supervised TRT for hypogonadism (typically 50-200mg/week).

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video describes supraphysiologic testosterone dosing (300-600mg/week) in a bodybuilding context, which is distinct from medically supervised TRT for hypogonadism (typically 50-200mg/week). At the dose ranges described, exogenous testosterone suppresses endogenous HPG axis function rapidly and elevates testosterone levels well beyond the physiological reference range, increasing risks for polycythemia, dyslipidemia, and cardiovascular remodeling. Bloodwork monitoring at week 6, while advisable, may not capture all emerging adverse changes, particularly early lipid and hematocrit shifts.
  • Bhasin et al. (2001, NEJM) confirmed that 300-600mg weekly of testosterone produces supraphysiologic levels and dose-dependent side effects including HDL suppression and hematocrit elevation, not just muscle gains.
  • The doses described in this video are 2-5 times higher than standard therapeutic TRT doses (50-200mg/week) used to treat diagnosed hypogonadism.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Bhasin et al. (2001, NEJM) confirmed that 300-600mg weekly of testosterone produces supraphysiologic levels and dose-dependent side effects including HDL suppression and hematocrit elevation, not just muscle gains.
  • The doses described in this video are 2-5 times higher than standard therapeutic TRT doses (50-200mg/week) used to treat diagnosed hypogonadism.
  • Rahnema et al. (2014, Fertility and Sterility) found that exogenous testosterone suppresses the HPG axis rapidly, sometimes causing long-lasting or permanent reduction in natural testosterone production.
  • Baseline natural testosterone level does not predict how an individual will respond to supraphysiologic exogenous doses. The creator's dose-selection logic based on a 900 ng/dL baseline has no pharmacokinetic research supporting it.
  • Baggish et al. (2017, Circulation) found decreased left ventricular function and structural cardiac changes in long-term anabolic steroid users. This risk was not mentioned in the video.
  • Finkelstein et al. (2013, NEJM) established that estradiol, not testosterone alone, drives several key side effects including fat accumulation and sexual dysfunction, which supports the creator's point about estrogen monitoring.
  • A 6-week bloodwork check is a reasonable practice, but standard basic panels may not capture early lipid shifts or polycythemia progression. Comprehensive panels including hematocrit and full lipid profiles are necessary.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @extraleonardo actually say?

The creator laid out a beginner testosterone-only cycle framework using weight-based dosing: "3 to 5 milligrams of test per kilo of body weight per week," which he calculated to roughly 300-400mg weekly for an average guy. He also suggested that if bloodwork looks clean at week 6, bumping to "4 to 6 milligrams per kilo" is still reasonable. He flagged estrogen management as the key variable to watch and added that guys with naturally high testosterone, around 900 ng/dL or above, might start closer to the higher end of that range. The framing was harm-reduction adjacent, not a blanket blast-everything approach. He used the phrase "clown cycle" to describe irresponsible high-dose use, which at least signals some awareness of risk.

To be clear: this is advice about supraphysiologic testosterone use in a bodybuilding context, not TRT. Those are very different things clinically, and conflating them does real damage to how people think about hormone health.

Does the science back this up?

Partially. The dose ranges he describes are within what research has actually studied, but that does not make them safe or medically endorsed. The landmark Bhasin et al. (2001, New England Journal of Medicine) dose-response trial used 25mg to 600mg of testosterone enanthate weekly in healthy men and found that lean mass and strength gains were dose-dependent, but so were adverse effects including hematocrit elevation and HDL suppression. The 300-600mg range he describes sits squarely in territory where side effects become clinically meaningful.

His weight-based dosing formula sounds precise, but it is not derived from peer-reviewed pharmacokinetic research for supraphysiologic use. It is gym-floor math dressed up as protocol. The 6-week bloodwork checkpoint is legitimate in principle. Rahnema et al. (2014, Fertility and Sterility) documented that exogenous testosterone suppresses the HPG axis rapidly, often within weeks, which is exactly why early monitoring matters.

What did they get wrong (or right)?

He got the harm-reduction instinct right. Telling beginners to find "your sweet spot" rather than chasing maximum dose is better advice than most of what circulates in these communities. The estrogen management point is also grounded in real physiology. Testosterone aromatizes to estradiol, and elevated estradiol can cause gynecomastia, water retention, and mood instability, per Finkelstein et al. (2013, New England Journal of Medicine).

What he got wrong, or at least glossed over: his claim that someone with a natural testosterone of 900 ng/dL or higher should "start close up to the 5 to 6 milligram per kilo dose" has zero clinical rationale. Baseline endogenous testosterone does not meaningfully predict how someone will respond to supraphysiologic exogenous doses. That logic sounds intuitive but it is not supported by pharmacokinetic data. He also skipped entirely over cardiovascular risk, which is not a footnote. Baggish et al. (2017, Circulation) found structural cardiac changes in long-term anabolic steroid users, including decreased left ventricular function. That deserved at least a sentence.

What should you actually know?

The doses described in this video are not TRT. Therapeutic testosterone replacement, used to treat diagnosed hypogonadism, typically involves 50-200mg per week, titrated to bring levels into the normal physiological range, roughly 400-900 ng/dL. What the creator is describing, 300-600mg weekly, would push most men to testosterone levels several times the upper limit of normal. That is anabolic steroid use, and the risk profile is different.

Key risks that were not mentioned include suppression of natural testosterone production, which can be long-lasting or permanent in some cases (Rahnema et al., 2014), polycythemia (dangerously elevated red blood cell count), liver stress with oral androgens, and psychological effects including aggression and dependency. The "bloods will be clean by week 6" framing is also optimistic. Some markers, particularly hematocrit and lipid panels, can shift in ways that are not immediately visible on basic panels.

If you are experiencing symptoms of low testosterone, the appropriate step is a blood panel through a licensed provider, not a TikTok dosing framework.

Bottom line: is this advice useful or dangerous?

It sits in an uncomfortable middle. The harm-reduction framing and emphasis on bloodwork monitoring are genuinely better than the alternative advice flooding these platforms. But presenting supraphysiologic steroid cycles as a structured, beginner-friendly protocol, with specific milligram-per-kilo formulas, normalizes a practice that carries real, documented cardiovascular and endocrine risks. The disclaimer that this is "not medical advice" does not neutralize the practical effect of giving people a specific dosing roadmap. Viewers should understand that "educational" framing does not make the underlying risks disappear.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Leonardo Bacha · TikTok creator

162.9K views on this video

This is not medical advice, but for educational/entertainment purposes only. Please do your own research.

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bhasin et al. (2001, nejm) confirmed?

Bhasin et al. (2001, NEJM) confirmed that 300-600mg weekly of testosterone produces supraphysiologic levels and dose-dependent side effects including HDL suppression and hematocrit elevation, not just muscle gains.

What does the video say about the doses described in this video?

The doses described in this video are 2-5 times higher than standard therapeutic TRT doses (50-200mg/week) used to treat diagnosed hypogonadism.

What does the video say about rahnema et al. (2014, fertility?

Rahnema et al. (2014, Fertility and Sterility) found that exogenous testosterone suppresses the HPG axis rapidly, sometimes causing long-lasting or permanent reduction in natural testosterone production.

What does the video say about baseline natural testosterone level does not predict how an individual?

Baseline natural testosterone level does not predict how an individual will respond to supraphysiologic exogenous doses. The creator's dose-selection logic based on a 900 ng/dL baseline has no pharmacokinetic research supporting it.

What does the video say about baggish et al. (2017, circulation) found decreased left ventricular function?

Baggish et al. (2017, Circulation) found decreased left ventricular function and structural cardiac changes in long-term anabolic steroid users. This risk was not mentioned in the video.

What does the video say about finkelstein et al. (2013, nejm) established?

Finkelstein et al. (2013, NEJM) established that estradiol, not testosterone alone, drives several key side effects including fat accumulation and sexual dysfunction, which supports the creator's point about estrogen monitoring.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Leonardo Bacha, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.